The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)

Efficacy of plogosertib (CYC149462), a novel orally bioavailable PLK1 inhibitor, on patient-derived models of colorectal cancer.

Mohammad  Zokaasadi

No Relationships to Disclose

Wylie  Watlington

No Relationships to Disclose

Divya  Dayanidhi

Employment - Xilis

Gabrielle  Rupprecht

Employment - Xilis

Research Funding - Xilis

Shannon  McCall

Honoraria - Takeda

Consulting or Advisory Role - AstraZeneca

Patents, Royalties, Other Intellectual Property - SciMed Solutions

Brian  Schwartz

Employment - Cyclacel

Jason  Somarelli

Research Funding - Bristol-Myers Squibb/Celgene; Karyopharm Therapeutics

Shiaowen  Hsu

Stock and Other Ownership Interests  - Xilis

Research Funding - Amgen